Thermal imaging of local skin temperature as part of quality and safety assessment of injectable drugs.

Injection of high-quality drugs can occasionally cause unexpected and unexplained local complications. As the current standard for drug quality control does not include an assessment of the local irritation effects of drugs, this effect may cause postinjection complications. Simultaneously, local irritation effects of the drugs can be assessed based on local tissue inflammation.

Cosmetic, Hemispherical Silicone Button for Emergency Application for Acne Abscess.

Accidental mechanical damage to acne and evacuation of the contents, resulting in a gateway for infection, is a problem that affects a large proportion of acne patients. Therefore, cosmetic, hemispherical silicone buttons were invented to help patients cope with this problem.

Brain hypoxia caused by respiratory obstruction which should not be forgotten in COVID-19 disease.

None. The authors declare that there are no potential conflicts of interest.

COVID-19: Artificial sputum, respiratory obstruction method and screening of pyolitic and antihypoxic drugs.

COVID-19 causes non-specific pneumonia, which has become a new cause of hypoxia, leading to the death of many patients. Today, there are no effective drugs that provide an urgent increase in blood oxygenation. Therefore, it is urgently necessary to develop drugs to increase blood oxygenation in order to save the lives of patients with the new coronavirus infection.

Stroke, Thrombosis, Bleeding and Addiction to Anticoagulants in the Context of Course Therapy: A Pharmacologic Perspective.

After reading with great interest the article entitled: "Non-vitamin K antagonist oral anticoagulants (NOACs) do not increase the risk of hepatic impairment in patients with non-valvular atrial fibrillation: insights from multi-source medical data" authored by Zhi-Chun Gu . and published by Reviews in Cardiovascular Medicine, we would like to add the following thoughts. Oral anticoagulants are generally accepted in patients with non-valvular atrial fibrillation to prevent thrombosis and stroke.